Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Clinical trial NCT05475366 · RECRUITING
Trial details
- NCT number
- NCT05475366
- Sponsor
- Institut Curie
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2028-12-11
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.